A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19
Public ClinicalTrials.gov record NCT04421508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus (COVID-19)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.
Study identification
- NCT ID
- NCT04421508
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 191 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2020 (Actual)
- Primary completion
- Dec 28, 2020 (Actual)
- Completion
- Jan 22, 2021 (Actual)
- Last update posted
- Feb 21, 2023
2020 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University Medical Center | Phoenix | Arizona | 85006 | — |
| Kaiser Permanente - Zion Medical Center | San Diego | California | 92120 | — |
| Kaiser Permanente - San Diego Medical Center | San Diego | California | 92123 | — |
| University of Miami Health System | Miami | Florida | 33136 | — |
| The Lung Research Center (St. Luke's) | Chesterfield | Missouri | 63017 | — |
| University of New Mexico Hospital | Albuquerque | New Mexico | 87106 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Mercy Health St. Vincent Medical Center | Toledo | Ohio | 43608 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Houston Methodist | Houston | Texas | 77030 | — |
| INOVA | Falls Church | Virginia | 22042 | — |
| St. Francis Medical Center | Richmond | Virginia | 23114 | — |
| Memorial Regional Medical Center | Richmond | Virginia | 23116 | — |
| Chippenham Medical Center | Richmond | Virginia | 23225 | — |
| Pulmonary Associates of Richmond | Richmond | Virginia | 23226 | — |
| St. Mary's Hospital | Richmond | Virginia | 23226 | — |
| Johnston-Willis Hospital | Richmond | Virginia | 23235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04421508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2023 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04421508 live on ClinicalTrials.gov.